Phase 1 trial of CV301 in combination with anti‐PD‐1 therapy in nonsquamous non‐small cell lung cancer
Sign Up to like & getrecommendations! Published in 2022 at "International Journal of Cancer"
DOI: 10.1002/ijc.34267
Abstract: CV301, a poxviral‐based vaccine, has been evaluated in a phase 1 clinical trial (NCT02840994) and shown to be safe and immunologically active (phase 1a). Preclinical data support a combination of CV301 with programmed death‐1 inhibitors,… read more here.
Keywords: combination; trial; cv301; phase ... See more keywords
Rate of EGFR mutation testing for patients with nonsquamous non-small-cell lung cancer with implementation of reflex testing by pathologists.
Sign Up to like & getrecommendations! Published in 2017 at "Current oncology"
DOI: 10.3747/co.24.3266
Abstract: BACKGROUND Testing for mutation of the EGFR (epidermal growth factor receptor) gene is a standard of care for patients with advanced nonsquamous non-small-cell lung cancer (nsclc). To improve timely access to EGFR results, a few… read more here.
Keywords: nonsquamous non; non small; reflex testing; egfr testing ... See more keywords